Clinical Data Purchases Protedyne’s Radius Platform

Clinical Data’s (www.clda.com) Cogenics division bought Protedyne’s (www.protedyne.com) Radius automation system. “This new equipment is required for the higher throughput studies that our clients are demanding,” points out Robert Bondaryk, Cogenics’ general manager. “This platform...
Source: Sartorius Stedim Biotech

Sartorius Inks Automation Cooperation Agreement with Siemens

Sartorius Stedim Biotech and Siemens agree to a long-term cooperation agreement in the area of automation
Putting a sample into the autosampler

Chromatographic Analysis for PAT

Continuous processing means real-time monitoring process analytical technology, and enhanced chromatographic techniques—such as the IEX and SEC techniques described by Phenomenex.

Octapharma Reports on a C$4.5M Advance to Prometic Related to Long-Term Supply of Plasma...

Firm gave Octapharma access to its prion-capture resin technology to manufacture solvent/detergent-treated plasma product for transfusion, octaplasLG®.

Pop Goes the Synthetic Cellular Control Switch

Synthetic biologists have built a modular, tunable protein switch that can sense environmental stimuli and respond by modifying cell functions such as the control of gene expression, the management of cellular traffic, the degradation of specific proteins, and the orchestration of protein-binding interactions.

Renova to Develop Transgenic Rabbits for Pharming’s Recombinant FVIII Program

Maryland firm announced birth of rhFVII transgenic rabbits at Chinese subsidiary.

Novasep Purchases Henogen for Upstream Processing Capabilities

Novasep can now offer complete antibody-drug conjugate manufacturing solution, covering early development to future commercial production.
Joint fund will back research over 10 years

GSK and EDB Pledge $35M to Augment Green Manufacturing in Singapore

Joint fund will back research over 10 years, with initial projects getting $3.5 million.

CSL Behring Plans $450M Expansion of Illinois, Australia Sites

Projects will add capacity to produce plasma intermediates in Kankakee, IL, site, and albumin in Melbourne

United Therapeutics Signs $7M Up-Front Licensing Deal for Pluristem’s Placental Cell Platform

Agreement gives United rights to use PLX platform for development of pulmonary hypertension product.

Recently Featured

Scroll Up